Therapeutic Asset Ratings

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Metformin Cardiovascular Disease	The University of Texas Health Science Center at San Antonio	P4	BBB (78)
Metformin Inherited Lipid Metabolism Disorder	RenJi Hospital	P4	BBB (78)
METHADONE Substance-Related Disorder	Rutgers, The State University of New Jersey	P4	BBB (78)
NORMAL HUMAN SERUM ALBUMIN Ascites	Centro Medico Issemym	P4	BBB (78)
oav101 Spinal Muscular Atrophy	Novartis Pharmaceuticals	P4	BBB (78)
Recombinant Human Thrombopoietin Thrombocytopenia	Sun Yat-sen University	P4	BBB (78)
Resmetirom Metabolic Dysfunction-Associated Steatohepatitis	City University of New York	P4	BBB (78)
Risperdal Major Depressive Disorder	Johns Hopkins University	P4	BBB (78)
Semaglutide Type 2 Diabetes Mellitus	Shanghai Jiao Tong University School of Medicine	P4	BBB (78)
Ticagrelor Myocardial Infarction	Assistance Publique - Hôpitaux de Paris	P4	BBB (78)
Tirzepatide Type 1 Diabetes Mellitus	Royal North Shore Hospital	P4	BBB (78)
Tolvaptan Hyponatremia	King's College Hospital NHS Trust	P4	BBB (78)
Topamax Migraine With Aura	Tongji Hospital	P4	BBB (78)
(±)-TRAMADOL Chronic Pain Syndrome	EMS	P4	BBB (78)
Tvp-1012 Parkinson Disease	Guangzhou Henovcom Bioscience Co. Ltd.	P4	BBB (78)
(+)-VINCRISTINE Mycosis Fungoides	Virogen Biotechnology Inc.	P4	BBB (78)
VINDESINE Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P4	BBB (78)
VINDESINE B-Cell Non-Hodgkin Lymphoma	Children's Cancer Group, China	P4	BBB (78)
Zelapar Major Depressive Disorder	Corium Innovations, Inc.	P4	BBB (78)
Cytosin-Arabinosid Acute Monocytic Leukemia	Chinese PLA General Hospital	P3	BBB (78)
Cytosin-Arabinosid Acute Myeloblastic Leukemia Without Maturation	Northwestern University	P3	BBB (78)
Cytosin-Arabinosid Acute Myelomonocytic Leukemia M4	University of Alberta	P3	BBB (78)
Cytosin-Arabinosid Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies	Children's Oncology Group	P3	BBB (78)
Daunorubicin Acute Myeloid Leukemia By FAB Classification	Wake Forest University Health Sciences	P3	BBB (78)
Deucrictibant C1 Esterase Inhibitor Deficiency	Institute for Asthma and Allergy	P3	BBB (78)

Showing 151 to 175 of 61,847 assets

PreviousPage 7 of 2474Next